share_log
Breakings ·  Oct 2 18:30
Vera Therapeutics Announces Late-Breaking Oral Presentation of Origin Phase 2B Long-Term Results at the American Society of Nephrology Kidney Week 2024
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment